Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Chen%2C+Gongyan%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Chen%2C+Gongyan%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Chen%2C+Gongyan%22&type=Person&sort=year
PubPharm (102)
1
Efficacy and safety of utidelone for the treatment of patients with locally advanced or metastatic non-small-cell lung cancer who have failed standard second-line treatment : A phase 2 clinical trial (BG01-1801)
enthalten in:
Cancer pathogenesis and therapy
| 2024
von
Shi, Y.
|
Chen, G.
|
Zhao, Y.
| +2
Wird geladen...
2
First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302) : a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial
enthalten in:
The Lancet. Respiratory medicine
| 2024
von
Zhong, H.
|
Sun, S.
|
Chen, J.
| +41
Wird geladen...
3
HLA-I Evolutionary Divergence Confers Response to PD-1 Blockade plus Chemotherapy in Untreated Advanced Non-Small Cell Lung Cancer
enthalten in:
Clinical cancer research : an official journal of the American Association for Cancer Research
| 2023
von
Jiang, T.
|
Jin, Q.
|
Wang, J.
| +38
CommentIn: Clin Cancer Res. 2023 Dec 1;29(23):4706-4708. - PMID 37756560
Wird geladen...
4
Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer : a multicentre, open-label, randomised phase 3 study
enthalten in:
The Lancet. Respiratory medicine
| 2023
von
Lu, S.
|
Zhou, J.
|
Jian, H.
| +41
CommentIn: Lancet Respir Med. 2023 Oct;11(10):857-859. - PMID 37244264
Wird geladen...
5
Central nervous system efficacy of rezivertinib (BPI-7711) in advanced NSCLC patients with EGFR T790M mutation : A pooled analysis of two clinical studies
enthalten in:
Lung cancer (Amsterdam, Netherlands)
| 2023
von
Yang, S.
|
Wu, S.
|
Zhao, Y.
| +54
Wird geladen...
6
Third-line or above anlotinib in relapsed and refractory small cell lung cancer patients with brain metastases : A post hoc analysis of ALTER1202, a randomized, double-blind phase 2 study
enthalten in:
Cancer innovation
| 2023
von
Cheng, Y.
|
Wang, Q.
|
Li, K.
| +8
Wird geladen...
7
Camrelizumab Plus Carboplatin and Pemetrexed as First-Line Treatment for Advanced Nonsquamous NSCLC : Extended Follow-Up of CameL Phase 3 Trial
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2023
von
Zhou, C.
|
Chen, G.
|
Huang, Y.
| +54
Wird geladen...
8
Third‐line or above anlotinib in relapsed and refractory small cell lung cancer patients with brain metastases : A post hoc analysis of ALTER1202, a randomized, double‐blind phase 2 study
enthalten in:
Cancer Innovation
| 2023
von
Cheng, Y.
|
Wang, Q.
|
Li, K.
| +8
Wird geladen...
9
Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non-small-cell lung cancer characterizes the features of response to PD-1 blockade plus chemotherapy
enthalten in:
Cancer communications (London, England)
| 2022
von
Wu, F.
|
Jiang, T.
|
Chen, G.
| +37
Wird geladen...
10
Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG) : a multicentre, double-blind, randomised phase 3 study
enthalten in:
The Lancet. Respiratory medicine
| 2022
von
Shi, Y.
|
Chen, G.
|
Wang, X.
| +20
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
102
Aufsätze
95
E-Artikel
95
E-Ressourcen
7
Gedruckte Aufsätze
Zeitschriftentitel
13
Journal of thoracic oncology : official publica...
9
Zhongguo fei ai za zhi = Chinese journal of lun...
6
The Lancet. Respiratory medicine
3
Annals of translational medicine
3
Cancer medicine
3
Chinese journal of lung cancer
3
Frontiers of medicine
3
Journal of clinical oncology : official journal...
3
Lung cancer (Amsterdam, Netherlands)
3
Molecular cancer
3
The Lancet. Oncology
3
Translational lung cancer research
2
Asia-Pacific journal of clinical oncology
2
Cancer Communications
2
Cancer Medicine
2
Cancer communications (London, England)
2
Clinical cancer research : an official journal ...
2
International journal of clinical and experimen...
2
JTO clinical and research reports
2
ResearchSquare.com
Alle anzeigen ...
weniger ...
Thema
82
Journal Article
45
Research Support, Non-U.S. Gov't
27
Randomized Controlled Trial
23
Multicenter Study
22
Clinical Trial, Phase III
20
EC 2.7.10.1
16
ErbB Receptors
14
EGFR protein, human
14
Protein Kinase Inhibitors
12
Antibodies, Monoclonal, Humanized
10
Antineoplastic Agents
10
Clinical Trial, Phase II
8
Quinazolines
8
anlotinib
8
chemotherapy
7
BG3F62OND5
7
Carboplatin
7
PD-1
6
04Q9AIZ7NO
6
49DFR088MY
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
71
2020-
30
2010-2019
1
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
82
Englisch
12
Chinesisch
Haven't found what you're looking for?
Wird geladen...